CAR T-cell therapy improves symptoms of myasthenia gravis, clinical trial shows

A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help ...
Everyday Health on MSN

How to manage nerve damage if you have ATTR-CM

Neuropathy may be an early symptom of ATTR-CM. Explore treatments and lifestyle tips that may help you maintain or improve ...

argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG

AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to ...
Everyday Health on MSN

Chronic inflammatory demyelinating polyneuropathy (CIDP) treatments

Explore comprehensive treatments for CIDP, including corticosteroids, plasma exchange, immunoglobulin therapy, and others.
MarketWatch

FDA Approves Amgen's UPLIZNA(R) (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease

The MarketWatch News Department was not involved in the creation of this content. New York, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug ...
Wane

FDA Approves Amgen’s UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease

New York, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen’s UPLIZNA ® (inebilizumab-cdon) for the ...
FiercePharma

Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod

Amid a swell of regulatory successes in the myasthenia gravis arena this decade, Amgen is wading into the fray with a new indication for its monoclonal antibody Uplizna. Thursday, the FDA greenlighted ...
Frontiers

Alterations in plasma cytokine profiles in generalized myasthenia gravis following different immunotherapeutic regimens

1 Department of Neurology, Chinese PLA Hospital, Beijing, China 2 Department of Pulmonary and Critical Care Medicine, Respiratory Research Institute, The Eighth Medical Center of PLA General Hospital, ...